Healthcare provider profile · identity verified

Robert C. Crouse, M.D.

Internal Medicine · HILLSBORO, OR · NPI 1659339083

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	805	215
Lisinopril	Lisinopril	385	109
Amlodipine Besylate	Amlodipine Besylate	303	79
Losartan Potassium	Losartan Potassium	292	84
Rosuvastatin Calcium	Rosuvastatin Calcium	274	71
Hydrochlorothiazide	Hydrochlorothiazide	248	68
Levothyroxine Sodium	Levothyroxine Sodium	233	63
Zolpidem Tartrate	Zolpidem Tartrate	225	47
Omeprazole	Omeprazole	198	56
Metoprolol Succinate	Metoprolol Succinate	178	45
Metformin Hcl	Metformin Hcl	175	45
Simvastatin	Simvastatin	175	47
Pravastatin Sodium	Pravastatin Sodium	165	46
Warfarin Sodium	Warfarin Sodium	135	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	129	21
Trazodone Hcl	Trazodone Hcl	129	34
Gabapentin	Gabapentin	125	34
Eliquis	Apixaban	123	36
Alprazolam	Alprazolam	122	27
Allopurinol	Allopurinol	103	31
Lovastatin	Lovastatin	102	26
Alendronate Sodium	Alendronate Sodium	97	28
Tamsulosin Hcl	Tamsulosin Hcl	92	28
Lorazepam	Lorazepam	84	18
Fluticasone Propionate	Fluticasone Propionate	83	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	21
Escitalopram Oxalate	Escitalopram Oxalate	79	17
Metformin Hcl Er	Metformin Hcl	75	18
Ozempic	Semaglutide	74	12
Pantoprazole Sodium	Pantoprazole Sodium	72	24
Furosemide	Furosemide	69	14
Bupropion Xl	Bupropion Hcl	67	21
Atenolol	Atenolol	62	16
Albuterol Sulfate Hfa	Albuterol Sulfate	59	31
Finasteride	Finasteride	58	15
Glipizide	Glipizide	58	14
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	23
Sertraline Hcl	Sertraline Hcl	50	19
Oxycodone Hcl	Oxycodone Hcl	47	13
Buspirone Hcl	Buspirone Hcl	46	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	12
Metoprolol Tartrate	Metoprolol Tartrate	44	suppressed
Prednisone	Prednisone	44	16
Meloxicam	Meloxicam	43	14
Montelukast Sodium	Montelukast Sodium	41	11
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	25
Carvedilol	Carvedilol	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	17
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Glipizide Er	Glipizide	20	suppressed
Fluconazole	Fluconazole	19	suppressed
Tadalafil	Tadalafil	19	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Valsartan	Valsartan	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Azithromycin	Azithromycin	15	12
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Colchicine	Colchicine	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Naproxen	Naproxen	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error